Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to "Thiolate DNAzymes on Gold Nanoparticles for Isothermal Amplification and Detection of Mesothelioma-derived Exosomal PD-L1 mRNA".

Analytical chemistry·2026
Same author

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026
Same author

CDK4/6 inhibition uncovers subtype-specific vulnerabilities and immune-related responses in esophageal squamous cell carcinoma.

Cell death & disease·2026
Same author

Seminal Fluid Biomarkers for Early Cancer Detection: A Systematic Review.

Biomedicines·2026
Same author

Thigmotactic navigation and functional enrichment of boar sperm in microfluidic channels.

Reproduction (Cambridge, England)·2026
Same author

Is platinum the new gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapies.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Video

Updated: Mar 20, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

12.1K

Engineering a 3D microfluidic culture platform for tumor-treating field application.

Andrea Pavesi1, Giulia Adriani1, Andy Tay2,3

  • 1Biosym IRG, Singapore-MIT Alliance for Research and Technology, 1 Create Way, 138602 Singapore, Singapore.

Scientific Reports
|May 25, 2016
PubMed
Summary

A novel microfluidic device applies alternating electric fields to cancer cells in a 3D matrix, reducing metastasis and proliferation. This technology shows promise for optimizing cancer treatments with minimal impact on normal cells.

More Related Videos

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

2.6K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.8K

Related Experiment Videos

Last Updated: Mar 20, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

12.1K
Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

2.6K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.8K

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Cell Biology

Background:

  • Current cancer therapies face limitations, necessitating novel strategies.
  • Alternating electric fields (AEF) show therapeutic potential but require mechanistic and safety clarification.
  • Understanding AEF effects on cancer and normal cells in a controlled environment is crucial.

Purpose of the Study:

  • To develop and validate a microfluidic device for applying AEF therapy to cancer cells within a 3D extracellular matrix.
  • To assess the impact of AEF on cancer cell metastasis and proliferation.
  • To evaluate the safety of AEF on non-cancerous endothelial cells.

Main Methods:

  • A novel microfluidic device with integrated electrodes was designed for AEF application.
  • Cancer cells and aggregates were cultured, including co-cultures with endothelial cells, within a 3D matrix.
  • Metastatic potential, proliferation rates, and cell morphology were analyzed post-AEF treatment.

Main Results:

  • AEF treatment significantly reduced the metastatic potential of cancer cells.
  • Proliferation rates of treated cancer cells were significantly lower than controls.
  • Endothelial cell morphology and proliferation remained largely unaffected by AEF treatment.

Conclusions:

  • The developed microfluidic system effectively applies AEF therapy in a 3D in vivo-like model.
  • AEF demonstrates efficacy in reducing cancer cell metastasis and proliferation with minimal impact on normal cells.
  • This platform can accelerate the optimization of AEF-based cancer therapies and combination treatments.